0000899243-22-030439.txt : 20220906 0000899243-22-030439.hdr.sgml : 20220906 20220906170835 ACCESSION NUMBER: 0000899243-22-030439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220906 DATE AS OF CHANGE: 20220906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dion Gisele CENTRAL INDEX KEY: 0001873088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 221229003 MAIL ADDRESS: STREET 1: C/O CYTEK BIOSCIENCES, INC. STREET 2: 46107 LANDING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-01 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001873088 Dion Gisele C/O INHIBIKASE THERAPEUTICS, INC. 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 1 0 0 0 Stock Option (right to buy) 0.95 2022-09-01 4 A 0 60000 0.00 A 2032-09-01 Common Stock 60000 60000 D The option shares vest 50% on each of the first two anniversaries of September 1, 2022. /s/ Milton H. Werner, Attorney-In-Fact 2022-09-06